Market revenue in 2023 | USD 182.4 million |
Market revenue in 2030 | USD 293.1 million |
Growth rate | 7% (CAGR from 2023 to 2030) |
Largest segment | Transvenous implantable cardioverter-defibrillators |
Fastest growing segment | Subcutaneous Implantable Cardioverter Defibrillators |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Transvenous Implantable Cardioverter-Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, BIOTRONIK, Boston Scientific Corp, MicroPort Scientific Corp, LivaNova PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable cardioverter defibrillators market will help companies and investors design strategic landscapes.
Transvenous implantable cardioverter-defibrillators was the largest segment with a revenue share of 89.36% in 2023. Horizon Databook has segmented the Italy implantable cardioverter defibrillators market based on transvenous implantable cardioverter-defibrillators, subcutaneous implantable cardioverter defibrillators covering the revenue growth of each sub-segment from 2018 to 2030.
Cardiac arrest cases suddenly increased in Italy, primarily due to a scarcity of resources during the pandemic. This created a demand for defibrillators in the country. According to the ECHOES Srl, cardiac arrest cases increased by more than 60% in 2020 compared to 2019.
In addition, the rising consumption of high-calorie food along with a sedentary lifestyle led to the high prevalence of heart diseases in the population of all ages in the country. This, in turn, increased the incidence of cardiac ailments in the country, which plays a significant role in market growth. Various institutes & authors stated a steady increase in the number of ICD implants in Italy over the historic period across age groups.
For instance, in February 2021, an article by Elsevier stated that ICD implants grew from 54 per million individuals in 2001 to 400 per million individuals in 2018. Moreover, a significant increase was noticed in ICD implants for patients suffering from heart failure (22.9% in 2001 to 46.8% in 2017). In addition, significant procedures were noticed in those aged 80 and over.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy implantable cardioverter defibrillators market , including forecasts for subscribers. This country databook contains high-level insights into Italy implantable cardioverter defibrillators market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account